Literature DB >> 12879285

Sural flap vascularization in arteritic patients: an anatomic study of 24 amputation specimens.

S Malokov1, D Casanova, G Magalon, A Branchereau.   

Abstract

Obliterating arteriopathy of the lower limbs is a classic contraindication for neurocutaneous islands flaps, particularly the sural flap. But recent literature reports examples of its successful application in arteritic patients. The aim of this work was to study the vascular anatomy of the sural flap in patients suffering from arteriopathy and its possible clinical application. Twenty-four specimens of leg amputation were studied. The mean age of the amputated patients was 68.5 years. The clinical signs of arteriopathy had been present for 3-16 years. In 10 cases amputation was carried out directly, in 14 cases after failed revascularization. The results of the dissection showed the theoretical possibility of a sural flap in almost all the cases (23 of 24) despite certain anatomical peculiarities. In the upper part of the leg the arterial network of the sural communicating nerve dominates that of the sural nerve; this should allow the use of a sural flap centered on this vascular axis. In the lower part, the arterial network of the sural communicating nerve is sustained by the perforators of the peroneal artery, then by the branches of the calcaneal artery, and finally by the lateral tarsal artery, which should allow the use of a sural flap with a very distal pedicle. The authors propose a theory which suggests that the progressive evolution of arteriopathy and the concomitant development of a supply network involving the vascularization of the sensory nerves induces the "anticipation" of a sural flap.

Entities:  

Mesh:

Year:  2003        PMID: 12879285     DOI: 10.1007/s00276-003-0141-y

Source DB:  PubMed          Journal:  Surg Radiol Anat        ISSN: 0930-1038            Impact factor:   1.246


  24 in total

1.  The anatomy of several free flap donor sites.

Authors:  G I Taylor; R K Daniel
Journal:  Plast Reconstr Surg       Date:  1975-09       Impact factor: 4.730

2.  A study of the human fibular communicating nerve.

Authors:  D D WILLIAMS
Journal:  Anat Rec       Date:  1954-11

3.  Peroneal artery bypass: a multifactorial analysis.

Authors:  C K Shortell; K Ouriel; J A DeWeese; R M Green
Journal:  Ann Vasc Surg       Date:  1992-01       Impact factor: 1.466

4.  Accompanying arteries of the cutaneous veins and cutaneous nerves in the extremities: anatomical study and a concept of the venoadipofascial and/or neuroadipofascial pedicled fasciocutaneous flap.

Authors:  H Nakajima; N Imanishi; S Fukuzumi; T Minabe; S Aiso; T Fujino
Journal:  Plast Reconstr Surg       Date:  1998-09       Impact factor: 4.730

5.  The posterolateral malleolar flap of the ankle: a distally based sural neurocutaneous flap--report of 14 cases.

Authors:  C Oberlin; B Azoulay; A Bhatia
Journal:  Plast Reconstr Surg       Date:  1995-08       Impact factor: 4.730

6.  Anatomical studies and five years clinical experience with the distally based medial fasciocutaneous flap of the lower leg.

Authors:  E B Jones; K Cronwright; A Lalbahadur
Journal:  Br J Plast Surg       Date:  1993-12

7.  Limitations of peroneal artery bypass grafting for limb salvage.

Authors:  B M Elliott; J G Robison; T E Brothers; M A Cross
Journal:  J Vasc Surg       Date:  1993-11       Impact factor: 4.268

8.  Clinical implications of the surgical anatomy of the sural nerve.

Authors:  J H Coert; A L Dellon
Journal:  Plast Reconstr Surg       Date:  1994-11       Impact factor: 4.730

9.  The blood supply to the skin of the leg: a post-mortem investigation.

Authors:  P A Haertsch
Journal:  Br J Plast Surg       Date:  1981-10

10.  The distally based sural artery flap.

Authors:  R L Huisinga; P Houpt; R Dijkstra; J B Storm van Leeuwen
Journal:  Ann Plast Surg       Date:  1998-07       Impact factor: 1.539

View more
  1 in total

1.  Application of the distally based sural neurocutaneous flaps in the management of foot and ankle defects in patients with diabetic foot.

Authors:  Jiezhi Dai; Yu Zhou; Shasha Mei; Hua Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.